APA
Click to copy
Fernández-Mincone, T., Contreras–Briceño, F., Espinosa-Ramírez, M., García-Valdés, P., López-Fuenzalida, A., Riquelme, A., … Barrera, F. (2020). Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications. Expert Review of Gastroenterology &Amp; Hepatology.
Chicago/Turabian
Click to copy
Fernández-Mincone, Tiziana, Felipe Contreras–Briceño, Maximiliano Espinosa-Ramírez, Patricio García-Valdés, Antonio López-Fuenzalida, A. Riquelme, J. Arab, D. Cabrera, M. Arrese, and F. Barrera. “Nonalcoholic Fatty Liver Disease and Sarcopenia: Pathophysiological Connections and Therapeutic Implications.” Expert Review of Gastroenterology & Hepatology (2020).
MLA
Click to copy
Fernández-Mincone, Tiziana, et al. “Nonalcoholic Fatty Liver Disease and Sarcopenia: Pathophysiological Connections and Therapeutic Implications.” Expert Review of Gastroenterology &Amp; Hepatology, 2020.
BibTeX Click to copy
@article{tiziana2020a,
title = {Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications},
year = {2020},
journal = {Expert Review of Gastroenterology & Hepatology},
author = {Fernández-Mincone, Tiziana and Contreras–Briceño, Felipe and Espinosa-Ramírez, Maximiliano and García-Valdés, Patricio and López-Fuenzalida, Antonio and Riquelme, A. and Arab, J. and Cabrera, D. and Arrese, M. and Barrera, F.}
}
ABSTRACT Introduction Nonalcoholic fatty liver disease (NAFLD) is currently one of the most common liver diseases worldwide. Recent data suggest that loss of skeletal muscle mass and function (i.e. sarcopenia) is highly prevalent and frequently overlooked in NAFLD patients. Experimental and clinical data suggest that the relationship between NAFLD and sarcopenia is pathophysiologically complex and bi-directional and there is a growing interest in unveiling how sarcopenia could influence NAFLD development and progression. Areas covered PubMed/MEDLINE was searched for articles related to concomitant occurrence of NAFLD and sarcopenia between January 2013 and April 2020. Areas covered in this review include: (1) updated sarcopenia diagnosis strategy, (2) discussion of current data on pathophysiological connections between NAFLD and sarcopenia, and (3) analysis of current and future therapeutic implications of this knowledge. Expert opinion Clinical studies describe a consistent association between NAFLD and sarcopenia, although a cause–effect relation remains to be determined. Active implementation of current diagnosis algorithms and optimized treatment can prevent sarcopenia related complications in subjects with NAFLD. Pathogenic pathways implicated in this relation are multiple and complex, a better understanding of them can provide novel biomarkers and targeted therapies that will hopefully have an important impact in NAFLD management.